De Placido Sabino, Rescigno Pasquale, Federico Piera, Buonerba Carlo, Bosso Davide, Puglia Livio, Izzo Michela, Policastro Tania, Di Lorenzo Giuseppe
Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy.
World J Clin Cases. 2014 Jun 16;2(6):228-31. doi: 10.12998/wjcc.v2.i6.228.
Prostate cancer is the most common non-cutaneous malignancy for men. The skeleton is the most common metastatic site but, following an improvement in survival, metastases in uncommon sites are being found more frequently in clinical practice, especially brain metastases. Despite the new drugs now available for metastatic castration resistant prostate cancer, no clinical evidence exists about their effectiveness on brain metastases. We describe the clinical history of 3 patients treated with cabazitaxel plus whole brain radiotherapy. These case reports demonstrate that cabazitaxel is highly active and well tolerated in brain metastases.
前列腺癌是男性最常见的非皮肤恶性肿瘤。骨骼是最常见的转移部位，但随着生存率的提高，在临床实践中，罕见部位的转移越来越常见，尤其是脑转移。尽管目前有新药可用于转移性去势抵抗性前列腺癌，但尚无关于其对脑转移有效性的临床证据。我们描述了3例接受卡巴他赛联合全脑放疗治疗患者的临床病史。这些病例报告表明，卡巴他赛在脑转移中具有高活性且耐受性良好。
